Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome - PubMed
12 hours ago
- #Immune Thrombocytopenia
- #Antiphospholipid Syndrome
- #Blinatumomab
- Blinatumomab used in combined immune thrombocytopenia and antiphospholipid syndrome.
- PMID: 41780009.
- DOI: 10.1056/NEJMc2516228.
- Includes information on publication types, grants, funding, and full text sources.